Table 5.
Regimen | Target population | Design | Registration number | Reference |
---|---|---|---|---|
AD5 CEA Vaccine | CRC Lung Cancer Breast Cancer |
Phase I, II | NCT01147965 | (274) |
CEA (6D) VRP Vaccine (AVX701) | CRC Lung Cancer Breast Cancer Pancreatic Cancer Colon Cancer |
Phase I, II | NCT00529984 | Completed |
CRC stage III | Phase I | NCT01890213 | Completed | |
DC/PANVAC or GM-CSF | CRC Metastasis Cancers |
Phase II | NCT00103142 | (275) |
Modified vaccine Ankara–5T | mCRC | / | ISRCTN54669986 | (276) |
GVAX Colon Vaccine | mCRC | Phase II | NCT02981524 | Completed |
MVA-Brachyury-TRICOM | CRC | Phase I | NCT02179515 | (277) |
Bavarian Nordic (BN)-CV301 | CRC | Phase I | / | (278) |